The right ventricle: Biologic insights and response to disease: Updated

Current Cardiology Reviews

Volumn 9, Issue 1, 2013, Pages 73-81

  Walker, Lori A ^a   Buttrick, Peter M ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Cardiomyocyte stucture function; Pathophysiology; Physiology; Right ventricle

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); BOSENTAN; DICHLOROACETIC ACID; INTERLEUKIN 6; MYOSIN HEAVY CHAIN; REGULATOR PROTEIN; SILDENAFIL; TROPONIN C; TUMOR NECROSIS FACTOR ALPHA;

ARTERY; COMPARATIVE STUDY; CONGENITAL HEART DISEASE; CYTOLOGY; DISEASE COURSE; ENZYME ACTIVITY; FALLOT TETRALOGY; FONTAN PROCEDURE; HEART AFTERLOAD; HEART DEVELOPMENT; HEART DISEASE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE PERFORMANCE; HEART OUTPUT; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE HYPERTROPHY; HUMAN; LUNG ARTERY PRESSURE; LUNG CIRCULATION; LUNG EMBOLISM; LUNG VASCULAR RESISTANCE; MYOFILAMENT; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; REVIEW; SEX DIFFERENCE;

EID: 84875833534     PISSN: 1573403X     EISSN: 18756557     Source Type: Journal    
DOI: 10.2174/157340313805076296     Document Type: Review

References (94)

1. Haddad F, Doyle R, Murphy DJ, Hunt SA. Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation 2008; 117(11):1436-48.
2. Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right ventricular function in cardiovascular disease, part I: Anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation 2008; 117(11):1436-48.
3. Voelkel NF, Quaife RA, Leinwand LA, et al. Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 2006; 114(17):1883-91.
4. Zaffran S, Kelly RG, Meilhac SM, Buckingham ME, Brown NA. Right ventricular myocardium derives from the anterior heart field. Circ Res 2004; 95(3):261-8.
5. Srivastava D, Olson EN. A genetic blueprint for cardiac development. Nature 2000; 407(6801):221-6.
6. Firpo C, Hoffman JI, Silverman NH. Evaluation of fetal heart dimensions from 12 weeks to term. Am J Cardiol 2001; 87(5):594-600.
7. Cassin S, Dawes GS, Mott JC, Ross BB, Strang LB. The Vascular Resistance of the Foetal and Newly Ventilated Lung of the Lamb. J Physiol 1964;171:61-79.
8. Chugh SS, Whitesel S, Turner M, Roberts CT, Jr., Nagalla SR. Genetic basis for chamber-specific ventricular phenotypes in the rat infarct model. Cardiovasc Res 2003; 57(2):477-85.
9. Ho SY, Nihoyannopoulos P. Anatomy, echocardiography, and normal right ventricular dimensions. Heart 2006;92 Suppl 1:i2-13.
10. Dell'Italia LJ. The right ventricle: anatomy, physiology, and clinical importance. Curr Probl Cardiol 1991; 16(10):653-720.
11. Ram F, Dhar M. A modified procedure for calculating person years of life lost. Janasamkhya 1992; 10(1-2): 1-12.
12. Dell'Italia LJ, Walsh RA. Acute determinants of the hangout interval in the pulmonary circulation. Am Heart J 1988; 116(5 Pt 1): 1289-97.
13. Chin KM, Kim NH, Rubin LJ. The right ventricle in pulmonary hypertension. Coron Artery Dis 2005; 16(1):13-8.
14. MacNee W. Pathophysiology of cor pulmonale in chronic obstructive pulmonary disease. Part One. Am J Respir Crit Care Med 1994;150(3):833-52.
15. Dell'Italia LJ. Mechanism of postextrasystolic potentiation in the right ventricle. Am J Cardiol 1990;65(11):736-41.
16. Santamore WP, Dell'Italia LJ. Ventricular interdependence: significant left ventricular contributions to right ventricular systolic function. Prog Cardiovasc Dis 1998; 40(4):289-308.
17. Ball R, Bache R, Cobb F, Greenfield JJ. Regional myocardial blood flow during graded treadmill exercise in the dog. J Clin Invest 1975; 55:43-9.
18. Tune J, Gorman M, Feigl E. Matching coronary blood flow to myocardial oxygen consumption. J Appl Physiol 2004; 97: 404-15.
19. Zong P, Tune J, Downey H. Mechanisms of oxygen demand/supply balance in the right ventricle. Exp Biol Med 2005; 230: 507-19.
20. O'Rourke RA, Dell'Italia LJ. Diagnosis and management of right ventricular myocardial infarction. Curr Probl Cardiol 2004; 29(1):6-47.
21. Topol EJ, Goldschlager N, Ports TA, et al. Hemodynamic benefit of atrial pacing in right ventricular myocardial infarction. Ann Intern Med. 1982; 96(5): 594-7.
22. Mizobuchi H, Tanigawa N, Komaki K, Ozawa Y. [The influence of atrioventricular asynchronous contraction on left and right ventricular performance]. J Cardiol 1992; 22(2-3):513-21.
23. Dubin AM, Feinstein JA, Reddy VM, Hanley FL, Van Hare GF, Rosenthal DN. Electrical resynchronization: a novel therapy for the failing right ventricle. Circulation 2003; 107(18):2287-9.
24. Bristow MR, Minobe W, Rasmussen R, et al. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J Clin Invest 1992; 89(3):803-15.
25. Wang GY, McCloskey DT, Turcato S, Swigart PM, Simpson PC, Baker AJ. Contrasting inotropic responses to alpha1-adrenergic receptor stimulation in left versus right ventricular myocardium. Am J Physiol Heart Circ Physiol 2006;291(4):H2013-7.
26. Denault AY, Chaput M, Couture P, Hebert Y, Haddad F, Tardif JC. Dynamic right ventricular outflow tract obstruction in cardiac surgery. J Thorac Cardiovasc Surg 2006; 132(1):43-9.
27. Heerdt PM, Pleimann BE. The dose-dependent effects of halothane on right ventricular contraction pattern and regional inotropy in swine. Anesth Analg 1996; 82(6):1152-8.
28. Salton CJ, Chuang ML, O'Donnell CJ, et al. Gender differences and normal left ventricular anatomy in an adult population free of hypertension. A cardiovascular magnetic resonance study of the Framingham Heart Study Offspring cohort. J Am Coll Cardiol 2002; 39(6):1055-60.
29. Natori S, Lai S, Finn JP, Gomes AS, et al. Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity. AJR Am J Roentgenol 2006;186(6 Suppl 2):S357-65.
30. Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham TP, Jr. Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson 1999; 1(1):7-21.
31. Hudsmith LE, Petersen SE, Francis JM, Robson MD, Neubauer S. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson 2005;7(5):775-82.
32. Sandstede J, Lipke C, Beer M, et al. Age-and gender-specific differences in left and right ventricular cardiac function and mass determined by cine magnetic resonance imaging. Eur Radiol 2000; 10(3):438-42.
33. Kawut SM, Lima JA, Barr RG, et al. Sex and race differences in right ventricular structure and function: the multi-ethnic study of atherosclerosis-right ventricle study. Circulation 2011; 123(22):2542-51.
34. Ventetuolo CE, Ouyang P, Bluemke DA, et al. Sex hormones are associated with right ventricular structure and function: The MESA-right ventricle study. Am J Respir Crit Care Med 2011; 183(5):659-67.
35. Brooks WW, Bing OH, Blaustein AS, Allen PD. Comparison of contractile state and myosin isozymes of rat right and left ventricular myocardium. J Mol Cell Cardiol 1987; 19(5):433-40.
36. Harding SE, O'Gara P, Jones SM, Brown LA, Vescovo G, Poole-Wilson PA. Species dependence of contraction velocity in single isolated cardiac myocytes. Cardioscience 1990; 1(1):49-53.
37. Kondo RP, Dederko DA, Teutsch C, et al. Comparison of contraction and calcium handling between right and left ventricular myocytes from adult mouse heart: a role for repolarization waveform. J Physiol 2006; 571(Pt 1):131-46.
38. Litten RZ, Martin BJ, Buchthal RH, Nagai R, Low RB, Alpert NR. Heterogeneity of myosin isozyme content of rabbit heart. Circ Res 1985; 57(3):406-14.
39. Polak JF, Holman BL, Wynne J, Colucci WS. Right ventricular ejection fraction: an indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease. J Am Coll Cardiol 1983; 2(2):217-24.
40. de Groote P, Millaire A, Foucher-Hossein C, et al. Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure. J Am Coll Cardiol 1998; 32(4):948-54.
41. Di Salvo TG, Mathier M, Semigran MJ, Dec GW. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 1995;25(5):1143-53.
42. Ghio S, Gavazzi A, Campana C, et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 2001;37(1):183-8.
43. Meluzin J, Spinarova L, Hude P, et al. Prognostic importance of various echocardiographic right ventricular functional parameters in patients with symptomatic heart failure. J Am Soc Echocardiogr 2005;18(5):435-44.
44. Sun JP, James KB, Yang XS, et al. Comparison of mortality rates and progression of left ventricular dysfunction in patients with idiopathic dilated cardiomyopathy and dilated versus nondilated right ventricular cavities. Am J Cardiol 1997;80(12):1583-7.
45. Mendes LA, Dec GW, Picard MH, Palacios IF, Newell J, Davidoff R. Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis. Am Heart J 1994;128(2):301-7.
46. Rudolph AM. The changes in the circulation after birth. Their importance in congenital heart disease. Circulation 1970;41(2):343-59.
47. Rudolph AM. The fetal circulation and its adjustments after birth in congenital heart disease. UCLA Forum Med Sci 1970;10:105-18.
48. Webb G, Gatzoulis MA. Atrial septal defects in the adult: recent progress and overview. Circulation 2006;114(15):1645-53.
49. Dell'Italia LJ, Walsh RA. Application of a time varying elastance model to right ventricular performance in man. Cardiovasc Res 1988;22(12):864-74.
50. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353(9162):1386-9.
51. Perez NG, Hashimoto K, McCune S, Altschuld RA, Marban E. Origin of contractile dysfunction in heart failure: calcium cycling versus myofilaments. Circulation 1999; 99(8):1077-83.
52. Perreault CL, Bing OH, Brooks WW, Ransil BJ, Morgan JP. Differential effects of cardiac hypertrophy and failure on right versus left ventricular calcium activation. Circ Res 1990; 67(3):707-12.
53. De Tombe PP, Wannenburg T, Fan D, Little WC. Right ventricular contractile protein function in rats with left ventricular myocardial infarction. Am J Physiol 1996;271(1 Pt 2):H73-9.
54. Fan D, Wannenburg T, de Tombe PP. Decreased myocyte tension development and calcium responsiveness in rat right ventricular pressure overload. Circulation 1997;95(9):2312-7.
55. Giuberti K, Pereira RB, Bianchi PR, Paigel AS, Vassallo DV, Stefanon I. Influence of ovariectomy in the right ventricular contractility in heart failure rats. Arch Med Res 2007;38(2):170-5.
56. Faber M, Dalinghaus M, Lankhuizen I, et al. Proteomic changes in the pressure overloaded right ventricle after 6 weeks in young rats: correlations with the degree of hypertrophy. Proteomics 2005;5:2519-30.
57. Buttrick PM, Kaplan M, Leinwand L, Scheuer J. Alterations in gene expression in the rat heart after chronic pathological and physiological loads. J Mol Cell Cardiol 1994; 26:61-7.
58. Schwartz K, Boheler K, de la Bastie D, Lompre A, Mercadier J. Switches in cardiac muscle gene expression as a result of pressure and volume overload. Am J Physiol 1992; 262:R364-9.
59. Takeyama D, Kagaya Y, Yamane Y, et al. Effects of chronic right ventricular pressure overload on myocardial glucose and free fatty acid metabolism in the conscious rat. Cardiovasc Res 1995;29:763-7.
60. Bishop SP, Altschuld RA. Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. Am J Physiol 1970; 218(1):153-9.
61. Oikawa M, Kagaya Y, Otani H, et al. Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. J Am Coll Cardiol 2005; 45(11):1849-55.
62. Piao L, Fang YH, Cadete VJ, et al. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle. J Mol Med (Berl) 2010;88(1):47-60.
63. Fang YH, Piao L, Hong Z, et al. Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle. J Mol Med (Berl) 2012; 90(1):31-43.
64. Kantor PF, Lucien A, Kozak R, Lopaschuk GD. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial longchain 3-ketoacyl coenzyme A thiolase. Circ Res 2000; 86(5):580-8.
65. Hassoun PM, Mouthon L, Barbera JA, et al. Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol 2009; 54(1 Suppl):S10-9.
66. Dorfmuller P, Perros F, Balabanian K, Humbert M. Inflammation in pulmonary arterial hypertension. Eur Respir J 2003;22(2):358-63.
67. Le Pavec J, Humbert M, Mouthon L, Hassoun PM. Systemic sclerosis-associated pulmonary arterial hypertension. Am J Respir Crit Care Med 2010;181(12):1285-93.
68. Gonzalez A, Ravassa S, Beaumont J, Lopez B, Diez J. New targets to treat the structural remodeling of the myocardium. J Am Coll Cardiol 2011;58(18):1833-43.
69. Liehn EA, Postea O, Curaj A, Marx N. Repair after myocardial infarction, between fantasy and reality: the role of chemokines. J Am Coll Cardiol 2011; 58(23):2357-62.
70. Campian ME, Hardziyenka M, Michel MC, Tan HL. How valid are animal models to evaluate treatments for pulmonary hypertension? Naunyn Schmiedebergs Arch Pharmacol 2006;373(6):391-400.
71. Stenmark KR, Meyrick B, Galie N, Mooi WJ, McMurtry IF. Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. Am J Physiol Lung Cell Mol Physiol 2009; 297(6):L1013-32.
72. Watts JA, Zagorski J, Gellar MA, Stevinson BG, Kline JA. Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats. J Mol Cell Cardiol 2006; 41(2):296-307.
73. Dias CA, Assad RS, Caneo LF, et al. Reversible pulmonary trunk banding. II. An experimental model for rapid pulmonary ventricular hypertrophy. J Thorac Cardiovasc Surg 2002; 124(5):999-1006.
74. Boxt LM, Katz J, Kolb T, Czegledy FP, Barst RJ. Direct quantitation of right and left ventricular volumes with nuclear magnetic resonance imaging in patients with primary pulmonary hypertension. J Am Coll Cardiol 1992; 19(7):1508-15.
75. Chen EP, Craig DM, Bittner HB, Davis RD, Van Trigt P. Pharmacological strategies for improving diastolic dysfunction in the setting of chronic pulmonary hypertension. Circulation 1998; 97(16):1606-12.
76. Louie EK, Lin SS, Reynertson SI, Brundage BH, Levitsky S, Rich S. Pressure and volume loading of the right ventricle have opposite effects on left ventricular ejection fraction. Circulation 1995;92(4):819-24.
77. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991; 115(5):343-9.
78. Sandoval J, Bauerle O, Palomar A, et al. Survival in primary pulmonary hypertension. Validation of a prognostic equation. Circulation 1994; 89(4):1733-44.
79. Badesch DB, Abman SH, Ahearn GS, et al. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126(1 Suppl):35S-62S.
80. Gavazzi A, Ghio S, Scelsi L, et al. Response of the right ventricle to acute pulmonary vasodilation predicts the outcome in patients with advanced heart failure and pulmonary hypertension. Am Heart J 2003;145(2):310-6.
81. Galie N, Hinderliter AL, Torbicki A, et al. Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension. J Am Coll Cardiol 2003; 41(8):1380-6.
82. Kass DA, Champion HC, Beavo JA. Phosphodiesterase type 5: expanding roles in cardiovascular regulation. Circ Res 2007; 101(11):1084-95.
83. Dell'Italia LJ, Starling MR, Blumhardt R, Lasher JC, O'Rourke RA. Comparative effects of volume loading, dobutamine, and nitroprusside in patients with predominant right ventricular infarction. Circulation 1985; 72(6):1327-35.
84. Vizza CD, Rocca GD, Roma AD, et al. Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension. Crit Care 2001; 5(6):355-61.
85. McKinsey TA. Therapeutic Potential for HDAC Inhibitors in the Heart. Annu Rev Pharmacol Toxicol 2012; 52:303-19.
86. Rouleau JL, Kapuku G, Pelletier S, et al. Cardioprotective effects of ramipril and losartan in right ventricular pressure overload in the rabbit: importance of kinins and influence on angiotensin II type 1 receptor signaling pathway. Circulation 2001; 104(8):939-44.
87. Quaife RA, Christian PE, Gilbert EM, Datz FL, Volkman K, Bristow MR. Effects of carvedilol on right ventricular function in chronic heart failure. Am J Cardiol 1998; 81(2):247-50.
88. Bolger AP, Sharma R, Li W, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002; 106(1):92-9.
89. Fan TH, Liang CS, Kawashima S, Banerjee SP. Alterations in cardiac beta-adrenoceptor responsiveness and adenylate cyclase system by congestive heart failure in dogs. Eur J Pharmacol 1987; 140(2):123-32.
90. Nootens M, Kaufmann E, Rector T, et al. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J Am Coll Cardiol 1995; 26(7):1581-5.
91. Walsh EP, Cecchin F. Arrhythmias in adult patients with congenital heart disease. Circulation 2007; 115(4):534-45.
92. Tongers J, Schwerdtfeger B, Klein G, et al. Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension. Am Heart J 2007; 153(1):127-32.
93. Goldstein JA, Harada A, Yagi Y, Barzilai B, Cox JL. Hemodynamic importance of systolic ventricular interaction, augmented right atrial contractility and atrioventricular synchrony in acute right ventricular dysfunction. J Am Coll Cardiol 1990; 16(1):181-9.
94. Dubin AM, Janousek J, Rhee E, et al. Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol 2005; 46(12):2277-83.